Judge Keeps Fraud Claims Against GSK Alive In Zofran MDL
A Massachusetts federal judge on Monday declined to nix fraud-based claims from multidistrict litigation alleging that GlaxoSmithKline PLC's anti-nausea drug Zofran is linked to birth defects, saying that claims about the...To view the full article, register now.
Already a subscriber? Click here to view full article